$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
乐伐替尼药代动力学受利福平的影响
2025-10-19 11:44:20
Check Details
乐伐替尼用于进展性碘难治性分化型甲状腺癌
2025-10-19 11:44:20
Check Details
卡博替尼治疗甲状腺髓样癌推荐剂量
2025-10-19 11:44:20
Check Details
多吉美获批治疗分化型甲状腺癌
2025-10-19 11:44:20
Check Details
索拉非尼为甲状腺癌患者提供新选择
2025-10-19 11:44:20
Check Details
乐伐替尼治疗转移性甲状腺癌的的效果显著
2025-10-19 11:44:20
Check Details
酮康唑对乐伐替尼在健康人群中药代动力学的影响
2025-10-19 11:44:20
Check Details
多吉美治疗分化型甲状腺癌的安全性
2025-10-19 11:44:20
Check Details
乐伐替尼治疗放射性碘难治性分化型甲状腺癌
2025-10-19 11:44:20
Check Details
索拉非尼延长转移性甲状腺癌患者生存期
2025-10-19 11:44:20
Check Details
乐伐替尼治疗分化型甲状腺癌安全有效
2025-10-19 11:44:20
Check Details
乐伐替尼治疗甲状腺癌客观缓解率为65%
2025-10-19 11:44:20
Check Details
1
2
...
2432
2433
2434
2435
2436
2437
2438
...
4149
4150
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Important Information for Safe Use of Ibrutinib
2
Comprehensive description of palbociclib
3
Pralsetinib: The RET Precision-Targeted Therapy That Rewrites the Treatment History of Rare Cancers
4
Detailed introduction to the instruction manual of revumenib
5
Ryeqo (Relugolix compound tablets) - long-term treatment for uterine fibroids
6
How effective is Ryeqo (Relugolix compound tablets)?
7
U.S. FDA approves Ryeqo to treat menorrhagia related to uterine fibroids in premenopausal women!
8
How much does Ryeqo cost? Where can I buy it in Liaoning?
9
Ryeqo - a good medicine that can effectively improve menorrhagia and pain caused by uterine fibroids
10
How much does Ryeqo cost? Is it available in Shandong now?
11
Comprehensive summary-the advantages, disadvantages and indications of different preparations of estradiol
12
What is the therapeutic effect of myfembree